Colorectal Cancer Clinical Trials in Washington

Showing 141-147 of 147 trials

Phase II Trial of LBH589 in Refractory Colorectal Cancer

NCT00690677

The purpose of this study is to determine the effects of the study drug, LBH589, on patients with metastatic colorectal cancer that has continued to grow despite previous treatment.

Colorectal Cancer

Swedish Medical Center29 participantsStarted Jun 2008

Seattle, Washington, United States

COMPLETED42 miles

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NCT00410579

RATIONALE: Learning about quality of life, symptoms, and health behaviors in colorectal cancer survivors may help to determine the long-term effects of colon and rectal cancer treatments and may help to improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is looking at patient-reported outcomes in long-term survivors of colon and rectal cancers.

Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more

NSABP Foundation Inc744 participantsStarted Nov 2006

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +197 more locations

Phase II Trial of LBH589 in Refractory Colorectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Colorectal Cancer Trials in Other Cities

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Other Conditions in Washington